Targeting nanoparticles to dendritic cells for immunotherapy

Methods in Enzymology
Luis J CruzCarl G Figdor

Abstract

Dendritic cells (DCs) are key players in the initiation of adaptive immune responses and are currently exploited in immunotherapy for treatment of cancer and infectious diseases. Development of targeted nanodelivery systems carrying vaccine components, including antigens and adjuvants, to DCs in vivo represents a promising strategy to enhance immune responses. Delivering particulate vaccines specifically to DCs and preventing nonspecific uptake by other endocytotic cells are challenging. Size represents a critical parameter determining whether particulate vaccines can penetrate lymph nodes and reach resident DCs. Specific delivery is further enhanced by actively targeting DC-specific receptors. This chapter discusses the rationale for the use of particle-based vaccines and provides an overview of antigen-delivery vehicles currently under investigation. In addition, we discuss how vaccine delivery systems may be developed, focusing on liposomes, PLGA polymers, and gold nanoparticles, to obtain safe and efficacious vaccines.

Citations

Jan 11, 2014·Expert Review of Vaccines·Roy MathewJeffrey S Kennedy
Oct 16, 2012·Journal of Drug Targeting·Arpit BhargavaPradyumna Kumar Mishra
Apr 29, 2015·Human Vaccines & Immunotherapeutics·Alicja E Grzegorzewska
Apr 4, 2015·Human Vaccines & Immunotherapeutics·Chi-Ying LinMing-Kung Yeh
Aug 17, 2016·Nanomedicine·Kleanthis FytianosBarbara Rothen-Rutishauser
Nov 22, 2016·Human Vaccines & Immunotherapeutics·Yimei JiaMichael J McCluskie
May 18, 2016·Experimental Biology and Medicine·Sourabh Shukla, Nicole F Steinmetz
Jan 10, 2018·The Journal of Immunology : Official Journal of the American Association of Immunologists·Patricia M Santos, Lisa H Butterfield
Aug 6, 2018·Journal of Nanobiotechnology·Hidenori MatsuoShun'ichi Kuroda
Nov 1, 2018·Journal of Cellular Biochemistry·Saeedeh RastakhizMahmoud Reza Jaafari
May 16, 2013·Scandinavian Journal of Immunology·D H Yi, S Appel
Jan 28, 2018·Artificial Cells, Nanomedicine, and Biotechnology·Salman BagheriHamid Kooshki
Jan 1, 2014·Current Opinion in Allergy and Clinical Immunology·Jonathan H Shannahan, Jared M Brown
Mar 16, 2017·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Hui QiuAndrew Z Wang
Aug 1, 2014·The Journal of Immunology : Official Journal of the American Association of Immunologists·Kartik SehgalKavita M Dhodapkar
Aug 9, 2017·Frontiers in Molecular Biosciences·Vimal K SinghRamesh Chandra
Jan 3, 2019·Biomaterials Science·Suresh Kumar GullaArabinda Chaudhuri
Jan 18, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Anna GraczykArkadiusz Chworos
Feb 7, 2021·Materials Science & Engineering. C, Materials for Biological Applications·Ana Luiza C de S L OliveiraRaimundo F de Araújo Júnior
Apr 4, 2020·International Immunopharmacology·Vida HashemiFarhad Jadidi-Niaragh
Apr 26, 2017·Advanced Drug Delivery Reviews·Julia E Vela RamirezNicholas A Peppas
Apr 22, 2021·Acta Biomaterialia·Jefferson O AbariciaRene Olivares-Navarrete
May 8, 2021·Experimental Biology and Medicine·Noah Trac, Eun Ji Chung
Jan 23, 2016·Biomaterials·C G Da SilvaLuis J Cruz
Jul 6, 2021·Advanced Drug Delivery Reviews·Danielle E LargeDebra T Auguste
Dec 18, 2018·ACS Biomaterials Science & Engineering·Riley P AllenJamal S Lewis
Sep 21, 2021·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Namita MahadikRajkumar Banerjee

❮ Previous
Next ❯

Related Concepts

Related Feeds

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Avian Influenza: Innate Immune Adjuvant (ASM)

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.